BioBel’s foundation rests upon the principle of physiologic restoration4the concept that optimal health is achieved when endogenous hormone patterns are restored, not simply replaced.
This fundamental distinction guides every aspect of our research, development, and clinical approach.
Our research integrates endocrine biology, metabolic biochemistry, chronobiology, and precision pharmacokinetics to target the root causes of hormonal imbalance.
Rather than applying a one-size-fits-all approach, we recognise that each patient’s endocrine system operates within unique rhythms and patterns that must be honoured and supported.
“The goal is not to override the body’s wisdom, but to restore its capacity to regulate itself.”
What we do
BioBel’s core therapeutic area addresses menopausal symptom relief through an innovative dual-capsule bioidentical hormone therapy approach. This investigational product, currently in development for Phase 2 clinical trials, represents a breakthrough in replicating natural physiologic hormone rhythms4a critical advancement over traditional hormone replacement therapies.
Estradiol (E2) + Estriol (E3)
Morning formulation carefully designed to support daytime hormonal needs & symptom management. This combination mirrors the body’s natural oestrogen patterns, providing targeted relief when women need it most during active hours.
Micronised Progesterone (P4)
Evening formulation expertly engineered to maintain critical endometrial protection and support natural sleep cycles. The timing optimises progesterone’s calming effects whilst ensuring proper uterine health.
This dual-capsule system is meticulously designed to replicate physiologic hormone rhythms whilst maintaining critical endometrial protection, offering women a therapy that works in harmony with their body’s natural processes.
The circadian-aligned dosing represents a paradigm shift from conventional static hormone delivery, acknowledging that hormone needs vary throughout the day.